Financhill
Back

Immunovant Stock Predictions

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 69.2% based on the past 4 years of stock performance.
  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $37.00. The Score for IMVT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 69.2% based on the past 4 years of stock performance.

Immunovant Stock Rating

Sell
42
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMVT is experiencing slight buying pressure.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
14.05

Prediction Charts

Market Cap:
5.38B
Price in USD:
37.00
Volume:
897.91K
Beta:
0.75

Technical Analysis

SMA50:
39.54
SMA100:
37.51
SMA200:
29.64
52-Wk Change:
108.45%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 37.00 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-5 34.26 36.61 36.80 34.17
Feb-6 36.58 36.44 36.99 35.17
Feb-7 36.47 35.24 36.47 35.17
Feb-8 35.22 35.26 35.69 34.83
Feb-9 35.85 35.48 36.18 35.26
Feb-12 33.95 36.69 36.75 33.95
Feb-13 35.84 36.92 38.24 35.51
Feb-14 37.26 37.82 38.17 36.96
Feb-15 38.07 37.78 38.92 37.32
Feb-16 37.41 37.14 37.78 36.89
Feb-20 38.14 37.48 39.20 37.44
Feb-21 37.50 36.52 37.96 36.02
Feb-22 36.45 35.99 36.67 35.83
Feb-23 35.94 37.00 37.46 35.94

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.19 per share, and a decrease next year of $0.02 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.